Under the deal, Novartis will acquire the exclusive global development and marketing rights to MOR106 for atopic dermatitis and all other potential indications. Based on the achievement of
Janssen Sciences Ireland is a subsidiary of Janssen R&D Ireland. Sylvant has approvals for the treatment of idiopathic multicentric Castleman’s disease (iMCD) in more than 40 countries such as
The study showed that patients who secured two doses of tanezumab separated by eight weeks experienced a statistically significant improvement in pain, physical function and the patients’ overall
Financial details have not been disclosed. Proleukin® is licensed in around 20 countries around the world and is primarily indicated for use in metastatic renal cell carcinoma, as
Baloxavir marboxil was discovered by Shionogi & Co. and is being developed globally by the Roche Group (which includes Genentech in the US) and Shionogi & Co. The drug
The US District Court for the District of New Jersey has granted PI against DRL to stop selling or importing its generic buprenorphine/naloxone sublingual film product. Indivior also
TPOXX is claimed to be the first drug with an indication for treatment of smallpox, which is a contagious and fatal infectious disease. The approval of small-molecule antiviral
The partnership will engage in the discovery and development of next-generation bispecific immunotherapies for multiple cancer indications. Under the deal, Immatics will secure an upfront fee of $54m
Visterra is engaged in the development of advanced antibody-based therapies for the treatment of patients with kidney diseases and other hard-to-treat diseases. Otsuka Pharmaceutical representative director and president
Idera said that majority of its stockholders voted in favor of the adoption of the merger agreement with BioCryst. BioCryst will pay $6m as transaction-related expenses to Idera,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.